Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression

Breast cancer is one of the most commonly diagnosed malignancies. Although endocrine therapy improves the survival of patients with hormone receptor (HR)-positive breast cancer, the post-endocrine therapy strategy for metastatic breast cancer remains challenging. Herein, we report two patients who b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dingyong, Tang, Shu, Ye, Rong, Li, Dongmei, Gu, Dejian, Chen, Rongrong, Zhang, Huan, Sun, Jianguo, Chen, Zhengtang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939121/
https://www.ncbi.nlm.nih.gov/pubmed/33692787
http://dx.doi.org/10.3389/fimmu.2021.610149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939121/
https://www.ncbi.nlm.nih.gov/pubmed/33692787
http://dx.doi.org/10.3389/fimmu.2021.610149

Ejemplares similares